New Alzheimer's Treatments: Early Detection and Prevention

Promising Alzheimer's Treatments

• 💡 An estimated 7 million Americans have Alzheimer's, with that number expected to double by 2060.
• 🎯 Two FDA-approved medications can slow cognitive decline by about 30% in patients with early symptoms.
• 🔑 These treatments work by removing amyloid, a substance that covers nerves and interferes with brain communication.

Preventing or Delaying Onset

• 🚀 International trials are exploring whether administering treatments before symptoms occur can prevent or delay the disease's onset.
• ⚠️ Current treatments do not reverse or stabilize the disease, highlighting the importance of early intervention.
• 🧠 Newer antibodies are more effective at removing amyloid, as shown on PET scans.

Bill Gates' Role in Research

• 💰 Bill Gates has contributed over $300 million to Alzheimer's research and is actively involved in trials.
• 🤖 He is interested in the role of Artificial Intelligence (AI) for analyzing the vast amounts of data related to Alzheimer's.
• 🔬 Gates has invested in a simple blood test to identify individuals at increased risk for Alzheimer's.

Early Detection and Diagnosis

• 🩸 A new blood test for phosphorylated tau 217 could indicate an increased risk for Alzheimer's.
• 🩺 If positive, this test could lead to a brain scan to detect amyloid, followed by potential medication before symptoms appear.
• 🩺 For the general population, not those with rare genetic defects, this early detection is crucial for potential prevention or delay.

Impact on Medical Practice

• ✅ Dr. Jon LaPook, a practicing internist, notes that these advancements have changed his practice, making him more aggressive in pursuing cognitive testing and prescribing medication.
• ⚠️ He emphasizes that current treatments are for early-onset dementia and do not offer hope for those with advanced Alzheimer's.
• 🔮 Future treatments might involve a cocktail of medications targeting amyloid, inflammation, and tau proteins.